Sciatica Acute

3

Review clinical trials related to Sciatica Acute. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care

The goal of this clinical trial is to compare transgluteal sciatic nerve block to standard of care to treat sciatic back pain in adult patients who present to the emergency department. The main question it aims to answer is: Is a transgluteal sciatic nerve block better than standard of care in improving pain in ER patients with sciatic back pain? If there is a comparison group: Researchers will compare patients who receive transgluteal sciatic nerve blocks to patients who receive standard of care to see if pain scores improve in ER patients with sciatic back pain. Participants will be randomized into the transgluteal sciatic nerve block group or the control group (standard of care). Participants will be asked to answer questions about their pain and will be asked to walk a timed short distance.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of California, San FranciscoUpdated: Jun 2, 2026Locations: 1
Eligibility criteria

Adults aged 18 years and older [+2]

Known allergy to study medications (e.g., local anesthetics) [+4]

Status: Recruiting

Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.

The goal of this clinical trial is to learn if a modification to metaxalone 640 mg can reduce low back and leg pain. The participants will be 18 to 80 years old, healthy with newly occurring back or leg pain. The main question aims to compare a group taking active treatment and a group taking a look-alike substance containing no active treatment. All participants will answer questions on Day 1, before treatment, and on 7-day after treatment, about: * Amount and quality of pain * Interference with physical activity * Interference with sleep

Participants needed: 50
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: Primus PharmaceuticalsUpdated: May 12, 2026Locations: 24
Eligibility criteria

No clinically significant conditions impacting quality or quantity of pain [+3]

Current use of other skeletal relaxants [+2]

Status: Recruiting

SNAG and SNME in Non-Specific Sciatic Pain

This study is designed as a crossover trial. All participants who meet the inclusion criteria and voluntarily agree to participate will be evaluated using the assessment methods detailed below. Subsequently, participants will be randomly assigned into two groups. The first group (Mulligan Concept Group - MCG) will receive the SNAG technique, while the second group (Neural Mobilization Group - NMG) will perform the Sciatic Nerve Mobilization Exercise (SNME). After the intervention, participants will be evaluated a second time. Ten days after this session, participants will be invited back. Those who were in the MCG group during the first session will be re-evaluated and then receive the SNGE intervention. Participants who were in the SNGE group during the first session will be re-evaluated and then receive the SNAG intervention. Following this second intervention, participants will be evaluated once again. Assessments will be done are Demographic Form, Visual Analogue Scale, Oswestry Disability Index, Joint Range of Motion, Five-times Sit-to-stand Test, Sit and Reach Test

Participants needed: 30
Trial details
Age: 20-50Biological sex: AllType: InterventionalSponsor: Istinye UniversityUpdated: Sep 8, 2025Locations: 1
Eligibility criteria

Adults between the ages of 20 and 50, [+4]

Individuals diagnosed with herniated disc or spinal stenosis by a physician, [+8]